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Abstract
Background: Plasmodium falciparum erythrocyte membrane protein 1(PfEMP1) is a family of variant surface antigens
(VSA) that mediate the adhesion of parasite infected erythrocytes to capillary endothelial cells within host tissues. Opinion
is divided over the role of PfEMP1 in the widespread endothelial activation associated with severe malaria. In a previous
study we found evidence for differential associations between defined VSA subsets and specific syndromes of severe
malaria: group A-like PfEMP1 expression and the “rosetting” phenotype were associated with impaired consciousness and
respiratory distress, respectively. This study explores the involvement of widespread endothelial activation in these associations.
Methods:We used plasma angiopoietin-2 as a marker of widespread endothelial activation. Using logistic regression analysis,
we explored the relationships between plasma angiopoietin-2 levels, parasite VSA expression and the two syndromes of
severe malaria, impaired consciousness and respiratory distress.
Results: Plasma angiopoietin-2 was associated with both syndromes. The rosetting phenotype did not show an independent
association with respiratory distress when adjusted for angiopoietin-2, consistent with a single pathogenic mechanism
involving widespread endothelial activation. In contrast, group A-like PfEMP1 expression and angiopoietin-2 maintained
independent associations with impaired consciousness when adjusted for each other.
Conclusion: The results are consistent with multiple pathogenic mechanisms leading to severe malaria and heterogeneity
in the pathophysiology of impaired consciousness. The observed association between group A-like PfEMP1 and impaired
consciousness does not appear to involve widespread endothelial activation.
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Background
Severe life threatening P. falciparum malaria is a major
cause of mortality and morbidity in young children in
sub-Saharan Africa. In endemic areas, severe malaria is
most prevalent in children under the age of five years,
before they acquire immunity to severe disease as a re-
sult of repeated exposure. Severe malaria manifests in
children in three partly overlapping syndromes; impaired
consciousness (IC), respiratory distress (RD), and severe
malarial anemia (SMA) [1]. Of these, IC and RD were
found to be the key indicators of life threatening malaria
in a hospital setting in sub-Saharan Africa [1].
The pathophysiological process underlying each of these
syndromes is still not understood. Disturbed microcircula-
tion is thought to play a major role [2]. In cerebral malaria
(CM) (severely impaired consciousness), sequestration of
parasite infected erythrocytes (IE) in the microvasculature
of the brain is thought to be important [3-6].
PfEMP1, a parasite encoded protein expressed on the
surface of the IE, interacts with host receptors on the
microvascular endothelia as well as unparasitized eryth-
rocytes (a phenotype referred to as rosetting) leading to
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sequestration of the IE in organs. PfEMP1 is therefore
thought to play a central role in parasite virulence. PfEMP1
is encoded by about 60 var genes per parasite genome and
undergoes antigenic variation. Switches in the expression of
the repertoire of var genes results in a high degree of plasti-
city in the antigenic and adhesive properties of the infecting
parasite population.
Epidemiological studies have shown a subset of var genes
preferentially expressed in young and non-immune chil-
dren to be associated with severe malaria especially in
children with IC [7-10]. This is consistent with 1) the hy-
pothesis that some PfEMP1 variants have growth advantage
in immunologically naïve children as the result of exhibit-
ing a superior ability to sequester [11-18] and 2) the ob-
served relationship between the density of sequestration in
vital organs such as the brain and fatal malaria [4,5,18].
Beside sequestration of IE, severe malaria is charac-
terised by systemic endothelial activation and widespread
release of activation markers such as von Willebrand
factor (vWF) [19], soluble ICAM-1(sICAM-1) [20] and
angiopoietin-2 (ang-2) [21,22]. As sequestration occurs in
the endothelial cells (ECs) of the microvasculature, it is
believed that PfEMP1 mediated adhesion of parasitized
red blood cells to the host microvasculature induces en-
dothelial activation compromising the vascular integrity
[23,24]. Recently, endothelial activation markers such as
ang-2, soluble Tie-2 receptor, vWF have been shown to be
associated with severe malaria [22,25]. Furthermore ang-2
is associated with retinopathy [25], a feature identified as a
surrogate marker for cerebral sequestration [5,26] and a
recent study found fibrin deposition in the brain to be as-
sociated with sequestration of IE [27]. If there is a connec-
tion between parasite var expression patterns and disease
severity, through mechanisms involving sequestration and
endothelial activation we would expect to observe a rela-
tionship between the expression of the var subset asso-
ciated with severe malaria and markers of endothelial
activation.
Previously, we showed through var expression profil-
ing of 217 clinical P. falciparum isolates, that expression
of a specific subset of “group A-like” PfEMP1 types is as-
sociated with severe malaria [8]. This was based on PCR
amplification of a region within the DBLα domain of
PfEMP1 and sequencing. Moreover, we showed that ex-
pression of these group A-like PfEMP1 types is associ-
ated primarily with the severe syndromes of IC, while
the parasite rosette phenotype was associated primarily
with RD [8,10]. In previous post-mortem studies of Thai
adults [3,4] and African children [5], the severity of IC
was shown to correlate with sequestration of IE by direct
binding to the vascular endothelia [18]. The subgroup of
vars expressed by the infecting parasites on the surface
of IE may therefore determine the level of endothelial
activation as suggested by [28].
In this study, we explored whether a relationship exists
between widespread endothelial activation (represented
by plasma ang-2 levels), parasite VSA expression and se-
vere malaria. Specifically, we investigated whether wide-
spread endothelial activation could provide a causal link
between the expression of the group A-like vars and IC
[10] on the one hand and rosette frequency and RD [10]
on the other. To this end we measured ang-2 levels in
the plasma of children from Kilifi, Kenya, presenting
with either severe or non-severe malaria.
Methods
Ethics statement
Ethical approval for this study was obtained from Kenya
Medical Research Institute (KEMRI) Ethical Review Com-
mittee (SSC 1131), and written, informed consent was ob-
tained from parents/guardians of the study participants.
Sample collection and clinical classification of patients
The method of sample collections was described in de-
tail in [8,10]. Severe malaria cases include children with
microscopically confirmed P. falciparum infection and
admitted to the hospital ward with impaired conscious-
ness (Blantyre coma score (bcs) <5 in patients aged
≥8 months or ≤3 in patients aged under 8 months) [29],
respiratory distress (deep “Kussmaul” breathing) [30], se-
vere malarial anemia (haemoglobin <5 g/dl) [1]. The se-
vere form of impaired consciousness was defined as
cerebral malaria (bcs ≤ 2).
Sampling of DBLα-tag sequence and classification
The method for amplification of DBLα-tag from cDNA
has been described in [31] and sequence classification
for the dataset used in this study is described in [8,10].
Briefly, a blood sample was taken from all the children
at admission. After removal of the white blood cells
(WBC), an aliquot (~100 μl) of the erythrocyte portion
was directly re-suspended in TRIzol and kept at −80 de-
grees till use. RNA was extracted from the frozen TRIzol
and cDNA synthesized using random hexamers. Using
degenerate primers a highly conserved region within the
DBLα-domain of vars was PCR amplified, cloned into
TOPO T-cloning vector, transformed into E. coli, and
100 colonies from each sample sequenced. The se-
quences were classified as described in [31,32]. Briefly
they were classified based on the number of cysteine res-
idues present (majority containing either two cysteine
(cys2) or four cysteine (cys4) [31]. The sequences were
also classified using network analysis according to
whether they fall into groups that tend not to share
polymorphic regions [33]. Group A-like vars belong to
cys2 and block sharing group 1 [33]. Each subgroup was
expressed as a percentage of the total sequences.
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Rosetting, IE surface antibody, and ang-2
Rosette frequency data was obtained as described previ-
ously [10]. IE surface antibodies data was obtained as de-
scribed in [10]. Briefly we measured each participant’s
IgG antibody levels (acquired as mean fluorescent inten-
sity (MFI)) to the infected erythrocyte surface of eight
ex vivo clinical isolates grown to the trophozoite stage
using flow cytometry. The eight isolates were selected
on the basis of their var expression (ranging from high
to low cys2 expression). The median MFI value of this
IE surface recognition by IgG against the eight isolates
was calculated for each participant [10].
Ang-2 level in the acute plasma was determined by a
commercial ELISA Kit from R & D (cat no; DANG20)
using the manufacture’s protocol.
PfHRP2 ELISA
Plasma PfHRP2 level was determined from the acute
plasma using ELISA. Three plasma samples from pa-
tients with high P. falciparum parasitemia were used to
determine both the dynamic range and the concentra-
tion of PfHRP2 using recombinant PfHRP2 protein ob-
tained from MyBioSource (Cat no MBS232321). These
plasma samples were then used to construct a standard
curve. The ELISA assay was performed in duplicates in
dilutions ranging from 1: 50 to 1:2000 and concentration
(ng/ml) calculated from the linear range of the standard
curve. Samples with OD readings greater than 20%
standard deviation in the duplicate well was repeated or
excluded from the analysis.
Statistical analysis
Stata version 11 was used for all statistical analyses and
P ≤0.05 was considered significant. Correlations between
variables were evaluated using Spearman’s rank correl-
ation coefficient or the 2-sample Wilcoxon rank-sum
(Mann–Whitney) test. Linear regression was used when
the outcome is a continuous variable and logistic regres-
sion when binary. All the regression analyses were ad-
justed for age. All independent variables that were
significant in a univariate analysis were included in
models with, either IC, or RD variable. Before use in a
regression analysis, parasite density both peripheral and
total (PfHRP2) and ang-2 were log-transformed. Rosette
frequency and group A-like expression were arcsine-
transformed as described in [8,10]. For all the logistic re-
gression analysis where IC, RD, or cerebral malaria is
the outcome, the syndrome was considered as a factor
[10], i.e. cases are those positive for the syndrome
(whether pure or mixed) and controls are those without
the syndrome of interest (whether severe or non-severe).
We tested the normality of residuals in linear regres-
sion models by examining the interquartile range of the
standardized residuals. None of the models had severe
outliers, giving no sufficient evidence to reject normality
at a 5% significance level.
We used the Hosmer-lemeshow goodness of fit test to
examine the goodness of fit for all logistic regression
models with all the models reported showing adequate
fit (P > 0.05). We also used the likelihood ratio (LR) χ2
improvement test to assess the effect of adding subse-




The samples used were from a published study [8] that
involved 217 study subjects. Of these, 213 had sufficient
plasma available to be included (see Additional file 1:
Figure S1 for patient characteristics). Previously, the var
expression profiles of the infecting parasites from these
children were determined [10] together with a measure of
the breadth of antibodies against antigens on the surface of
the IE [8] present at the time of disease. Rosette frequency
was determined for parasites from 130 of the samples [10].
We used ang-2 as a marker of widespread endothelial
activation because unlike sICAM-1 [34] and vWF [35,36]
that can be released from non-ECs or ang-1 which is en-
tirely from non-endothelial source, ang-2 is only released
from activated ECs [37,38]. Moreover, ang-2 is relatively
stable under freeze-thaw cycling [39].
Ang-2 levels are associated with the severe malaria
syndromes; impaired consciousness and respiratory distress
Consistent with previous studies [21,25], analysis of 213
children’s plasma showed that ang-2 levels were higher
in children with severe malaria compared to those who
were non-severe (Figure 1A: Mann–Whitney U test Z =
6.5, P < 0.0001, N = 213).
Since severe malaria in African children presents in three
overlapping syndromes [1], these syndromes may be differ-
entially associated with markers of endothelial activation.
To explore this, we used ang-2 as the dependent variable in
a multivariable linear regression model that considered host
age, IC, and RD as explanatory variables (SMA was not in-
cluded due to few samples with this clinical phenotype).
Both RD and IC displayed significant and independent as-
sociations with ang-2 (Figure 1B) suggesting that endothe-
lial activation may play a role in the pathophysiology of
both syndromes.
The association of IE surface antigen profiles with plasma
angiopoietin-2
Given the potential link between cytoadherence and
endothelial activation we explored two measures of vari-
ant surface antigen (VSA) expression: rosetting and
group-A like var, in relation to ang-2 levels. A significant
positive correlation was found between ang-2 and both
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group A-like var expression (Figure 2A) and rosetting
(Figure 2B). To explore whether these relationships be-
tween the measures of VSA and ang-2 were due to direct
parasite:host interactions, we tested whether the associa-
tions were maintained when we split the analysis into se-
vere and non-severe cases (Figure 2C-F). Neither group
A-like expression nor rosetting showed evidence for an as-
sociation with ang-2 among non-severe cases (Figure 2E-F).
This suggests that disease severity is a confounder, i.e. the
observed associations between VSA expression and ang-2
are due to the fact that both are associated with disease se-
verity rather than their direct associations with each other.
Group A-like expression and ang-2 are independently
associated with impaired consciousness
We explored further whether the previously observed re-
lationship between the group A-like var subgroup ex-
pression and IC [10] may involve widespread endothelial
activation. We did not consider rosetting here because
we showed previously that it has no association with IC
within this dataset [10].
We used age-adjusted logistic regression models pre-
dicting IC with group A-like var expression and ang-2 as
independent variables. First, each of them was used as the
only explanatory variable in an age-adjusted model and
then in combination to adjust for one another. As shown
in Figure 3A and Table 1, model 6A, despite a moderate
reduction in the odds ratio (OR) when adjusted for ang-2,
the group A-like var subgroup expression remained sig-
nificantly associated with IC. Similarly, ang-2 remained
significantly predictive of IC when adjusted for group A-
like var expression (Figure 3B and Table 1, model 6A). A
positive improvement to the fit of the model was observed
when both variables were considered compared to either
considered alone (likelihood ratio χ2 = 22.5, P < 0.001 and
χ2 = 6.5, P < 0.01 respectively, compared to group A-like
and ang-2 considered alone). These results suggest that
the group A-like var expression and ang-2 are independ-
ently associated with IC.
Next we examined the relationship between ang-2
levels and carriage at the time of disease of antibodies to
the IE surface. Previously [8,10] we measured levels of
these antibodies against 8 parasite isolates by flow cy-
tometry and the median value of this IE surface recogni-
tion by IgG was calculated (henceforth called “IE surface
antibodies”). IE surface antibodies showed a negative as-
sociation with group A-like expression and IC [10]. We
asked whether this negative association with IC might
involve a causal network that includes ang-2. This would
be expected if, for example, IE surface antibodies, by
inhibiting cytoadherence mediated by group A-like
PfEMP1 protect against endothelial activation and sub-
sequently IC. We therefore tested the independence of
IE antibodies, ang-2 and IC using logistic regression. As
illustrated in Figure 3A and Table 1 model 7A, adjusting
for IE surface antibodies reduced the estimated relation-
ship between group A-like and IC, but showed no effect
on the relationship between ang-2 and IC (Figure 3B
and Table 1 model 8A). Similarly, adjusting for ang-2
did not alter the relationship between IE surface anti-
bodies and IC (Figure 3C). Thus unlike group A-like var
expression, the relationship between IE antibodies and
IC appears to be independent of ang-2. Overall, a similar
observation was made when CM (bcs ≤ 2) was consid-
ered as the outcome (Table 1 model 1B, 6B, 7B and 8B).
Overall, the independence between group A-like var
expression and IE antibodies on the one hand and ang-2
on the other, in relation to their associations with IC
suggest that distinct pathways may link group-A like var
expression and widespread endothelial activation to IC.
Figure 1 Plasma ang-2 level and clinical malaria (N = 213). A) Plasma ang-2 level and severe malaria. Shown in blue is the median and interquartile
range, P-value determined by Mann–Whitney U test. B) Relationship between ang-2 plasma level and severe malaria syndromes: Plot of regression
coefficient and 95% confidence interval obtained from an age-adjusted multi-variable regression model that predicted ang-2 using impaired consciousness
and respiratory distress as explanatory variables (N = 213).
Abdi et al. BMC Infectious Diseases 2014, 14:170 Page 4 of 11
http://www.biomedcentral.com/1471-2334/14/170
Previous analysis of this dataset suggested that the associ-
ation between group A-like var expression and IC is inde-
pendent of peripheral parasite density [10]. We explored
this further with another plasma marker, PfHRP2 (thought
to be a marker of parasite burden within the host [40]).
PfHRP2 has recently been found to have a strong relation-
ship with retinopathy positive cerebral malaria [41]. To test
the effect of PfHRP2 on the relationship between group A-
like expression and IC, we measured plasma PfHRP2 and
tested its relation with group A-like expression and ang-2
using Spearman’s rank correlation. Consistent with the ob-
servation made with the peripheral parasitemia (Figure 3D),
group A-like var expression showed no evidence for an as-
sociation with PfHRP2 (Figure 3E). Furthermore, both
group A-like expression and PfHRP2 showed independent
associations with IC in an age-adjusted logistic regression
analysis (Table 1 model 10). In contrast PfHRP2 and ang-2
showed evidence for non-independence in their associa-
tions with IC (Table 1, model 12). These results suggest that
group A-like expression and ang-2 have contrasting rela-
tionship with parasite load and the latter seem to be more
important for ang-2 release.
Associations between Rosette frequency, parasitemia,
endothelial activation, and respiratory distress
Previously, we found that RD showed evidence for an as-
sociation with peripheral parasitaemia and rosette fre-
quency within this dataset [10]. Above, we showed ang-2
Figure 2 The relationship between ang-2 and group A-like expression and the rosetting phenotype of the infecting parasite. Scatter
plots showing the relationship between A) ang-2 and group A-like expression, B) ang-2 and rosetting frequency for all the samples. C & D and
E & F are repeats of A and B analysis within severe and non-severe cases respectively.
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level is associated with RD (Figure 1B and Table 2), but
that appeared not to be a direct relationship between
rosetting and ang-2 within the non-severe cases (Figure 2F)
suggesting a lack of direct causal relationship. To further
explore whether the relationship between rosetting and
RD involves endothelial activation measured by plasma
ang-2, we used rosette frequency and ang-2 as explanatory
variables in age-adjusted logistic regression models pre-
dicting RD. We then tested the independence of rosetting
frequency and ang-2 in their associations with RD. When
ang-2 and rosette frequency were included together in the
analysis the OR of the relationship between rosetting and
RD dropped by almost a half and the association was no
longer statistically significant (Figure 4A and Table 2 model
7). In contrast ang-2 retained its significant associations
with RD (Figure 4B, Table 2 model 7). Adding rosetting into
a model that considered ang-2 alone showed no evidence
of improving the fit (χ2 = 2.2, P = 0.14). Taken together
these and the results shown in Figure 2F do not support a
strong causal link between rosetting and endothelial
activation, though Figure 4A is consistent with some level
of non-independence. This is potentially well explained by
the association between both endothelial activation and
rosetting with parasite density (Figure 4C-F) and the non-
independent associations of rosetting frequency with RD
when adjusted for ang-2 and parasitaemia in age-adjusted
logistic regression analysis (Table 2 models 12 and 13).
Discussion
In this study we tested whether a marker of widespread
endothelial activation, plasma ang-2 levels throw light on
our previously reported associations between expression of
group A-like var genes and malaria with IC on the one
hand and rosetting frequency with RD on the other [10].
Previously, a link between in vivo endothelial dysfunction
and severe malaria has been established [21]. In addition, a
further study in Malawi revealed that plasma ang-2 is
higher in children with retinopathy positive cerebral mal-
aria [25]. As retinopathy is a surrogate marker of cerebral
sequestration [5,26,42], this supports the idea that parasite
Figure 3 Group A-like var expression and ang-2 have independent association with impaired consciousness. A plot of odds ratio and
95% CI obtained from age-adjusted logistic regression models predicting impaired consciousness using; A) Group A-like expression before and
after adjusting either for ang-2 or IE surface antibodies B) plasma ang-2, before and after adjusting for either group A-like expression or IE surface
antibodies C) IE surface antibodies, before and after adjusting for either group A-like expression or ang-2. Asterisk indicate significance. Scatter
plots showing the relationship between D) group A-like expression and peripheral parasite density, E) group A-like expression and PfHRP2.
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sequestration causes endothelial activation. The recent
identification of endothelial protein C receptor (EPCR) as a
receptor for severe disease-associated PfEMP1 and the
hypothesis that this interaction may drive inflammation
[27,28] gives further support to this notion. Following these
observations, we explored whether group A-like PfEMP1
may cause higher levels of activation of these cells and release
of ang-2, exacerbating inflammation and leading to coma.
Though group A-like var subgroup showed a signifi-
cant but weak association with ang-2 this association
dropped out when severe and non-severe cases are con-
sidered separately (Figure 2). Moreover, group A-like var
expression was independently associated with IC when
adjusted for ang-2 in a logistic regression model (Figure 3,
and Table 1). This is consistent with a model in which 1)
IE expressing group A-like PfEMP1 can sequester by bind-
ing to ECs in the absence of widespread endothelial activa-
tion and inflammation and 2) expression of group A-like
var contribute to IC in a pathway at least partly independ-
ent of widespread ang-2 release.
Recent in vitro studies have shown that IE expressing
PfEMP1 subsets containing domain cassette 8 (DC8)
and 13 (DC13) can bind to brain endothelial cells (via
EPCR) in a manner that is not dependent on the induc-
tion of adhesion molecules such as ICAM-1 [15,17,43]
that are induced by inflammation. The expression of
these PfEMP1 subsets (i.e. DC8 and DC13) in P. falcip-
arum isolates sampled from children with severe and
non-severe malaria have been shown to be associated
with severe malaria [9]. Therefore, in the presence of
low host IE surface antibodies, the expression of group
A-like PfEMP1 (such as DC13) may give the parasite
growth advantage in the initial infection, dominating the
sequestered biomass, and causing impaired conscious-
ness before widespread endothelial activation and in-
flammation occurs.
Our converse observation was that the relationship be-
tween ang-2 and IC is not altered by adjustment for
group A-like var expression (Figure 3 and Table 1). This
suggests that parasites expressing group A-like PfEMP1
do not form part of an explanatory link between ang-2
and IC. This in turn suggests that endothelial activation
does not confer a growth advantage to parasites express-
ing group A-like PfEMP-1 through cytoadherence to in-
ducible adhesives molecules such as ICAM-1. ICAM-1
mediated IE cytoadhesion is known to be mediated by a
Table 1 Age-adjusted logistic regression models predicting (A) impaired consciousness and (B) cerebral malaria (N = 213)
A: impaired consciousness B: cerebral malaria
Models Explanatory variables OR (95% CI) P value OR (95% CI) P value
1$ Group A-like 4.5(1.7,11.4) 0.002 2.97(1.14, 7.76) 0.026
2 ang-2 3.0(1.9, 4.7) 0.000002 2.52(1.57, 4.03) 0.00012
3$ Parasite density (peripheral) 1.37(1.12, 1.67) 0.002 1.46(1.16, 1.84) 0.001
4 PfHRP2 1.34(1.13, 1.60) 0.001 1.43(1.17, 1.74) 0.0004
5$ IE surface antibodies 0.96(0.94, 0.98) 0.00002 0.96(0.94, 0.99) 0.001
6 Group A-like 3.5(1.32, 9.44) 0.012‡ 2.3(0.84,6.33) 0.1
ang-2 2.82(1.78, 4.46) 0.000009‡ 2.38(1.48, 3.82) 0.0003‡
7$ Group A-like 2.3(0.86, 6.3) 0.097 1.73(0.63, 4.77) 0.3
IE surface antibodies 0.96(0.94, 0.98) 0.0001‡ 0.97(0.95, 0.99) 0.003‡
8 ang-2 2.87(1.76, 4.66) 0.00002‡ 2.35(1.43, 3.85) 0.001‡
IE surface antibodies 0.96(0.94, 0.98) 0.00007‡ 0.97(0.95, 0.99) 0.003‡
9$ Group A-like 4.15(1.6, 10.7) 0.003‡ 2.65(0.99, 7.08) 0.05
Parasite density (peripheral) 1.3(1.1, 1.65) 0.005‡ 1.43(1.14, 1.81) 0.002‡
10 Group A-like 4.24(1.6, 11.21) 0.004‡ 2.68( 0.98,7.37) 0.05
PfHRP2 1.32(1.12, 1.57) 0.001‡ 1.40(1.15, 1.71) 0.001‡
11 ang-2 2.7(1.7, 4.3) 0.00005‡ 2.17(1.33, 3.53) 0.002‡
Parasite density (peripheral) 1.21(0.97, 1.5) 0.09 1.32(1.04, 1.68) 0.023‡
12 ang-2 2.6(1.60, 4.24) 0.005‡ 2.07(1.24, 3.44) 0.005‡
PfHRP2 1.18(0.98, 1.41) 0.080 1.28(1.04,1.58) 0.019‡
The analysis in this table considers the outcomes IC and CM as factors, which means non-IC/CM severe cases are included in the control group and hence the
analysis is conservative. The association of group A-like with impaired consciousness is independent of ang-2 (model 6). Similarly the IE surface antibodies and
ang-2 show independent association with impaired consciousness (Model 8A, compare with model 7A). In Model 6B, the association of group A-like expression
with CM is not statistically significant when ang-2 was considered. However, the odd ratios of both the unadjusted and ang-2 adjusted are similar in magnitude
and direction. $ indicate models that have been published in [8,10] and repeated here for comparison. ‡ = variables that improved the fit of the model using LR
χ2 improvement test. PfHRP2 data was obtained for 207 out of the 213 samples.
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subset of PfEMP1 and has been shown to be associated
with cerebral malaria [44-46]. It has been proposed that
pathogenesis in this case is mediated through a positive
feedback whereby cytoadhesion promotes ICAM-1 ex-
pression which further promotes cytoadhesion [47]. If IE
adhesion to ICAM-1 or other inducible adhesive mole-
cules is encoded by subsets of both group A and not
group A-like PfEMP1 it would provide an explanation
for why ang-2 association with IC remains independent
of the group A-like var expression. We are now in a
position to refine approaches to measure var gene ex-
pression in clinical isolates and explore their associations
with different pathogenic mechanisms.
It is important to note that that sequestration per se
does not need to play a direct role in endothelial activa-
tion for it to be important in disease pathology. Since all
IE are thought to sequester, high parasite burden, what-
ever the underlying cause could lead to endothelial
activation independent of the PfEMP1 cytoadhesive pro-
file. This is consistent with the findings of two in vitro
studies that used human brain microvascular endothelial
cell lines (HBMEC [48,49] and hCMEC/D3 [50] to test
whether cytoaherance to ECs is important for endothe-
lial activation. Although they differ in their conclusion
on what may be responsible for EC activation, they both
agree that binding of IE to the ECs is not necessary for
endothelial activation. The study by zougbede et al. fur-
ther demonstrate that contact between the IE and ECs is
not required for endothelial activation [50]. Again in a
post-mortem study, Silamut et al. [4] observed, general-
ised endothelial activation, not confined to sites of para-
site sequestration in brain samples from Thai and
Vietnamese adults who died from severe malaria, further
supporting the possibility of endothelial activation oc-
curring independently of IE binding [4]. Moreover, sera
from patients with falciparum malaria were found to in-
duce increased expression of substance P, an observation
that was not made with sera from healthy controls [51].
These results raise the possibility that widespread endo-
thelial activation is independent of direct cytoadherence
of the IE to the vascular endothelia and that parasite de-
rived circulating factors may be responsible for endothe-
lial activation.
Clearly, parasite density (in the context of falciparum
malaria) is likely to be an important determinant of
endothelial activation. Parasite density may contribute to
endothelial activation by increasing the amount of re-
leased microparticles, free haemoglobin, and other mole-
cules. Recently, levels of plasma PfHRP2 (thought to
represent parasite load [40,52], though found not useful
as a marker of parasite load in a study in Kilifi [53]), was
found to differentiate between retinopathy positive CM
from retinopathy negative CM [41]. Considering this,
the finding that ang-2 is higher in retinopathy positive
CM cases compared to retinopathy negative cases [25] is
consistent with parasite load being an important deter-
minant of endothelial activation. Moreover, previous
work suggests that high parasite burden would lead to
an increase in lactic acid production [54], causing acid-
osis and RD. In this context we found ang-2 to be sig-
nificantly correlated with parasite density (Figure 4E-F)
and base-excess (Additional file 1: Figure S2). Parasite
density was shown to be associated with respiratory dis-
tress (Table 2) which is a manifestation of metabolic
acidosis [30], measured by base excess.
Our var gene expression measurements and assessment
of rosetting phenotype come from circulating parasites ra-
ther than sequestered ones. Since sequestration and micro-
vascular obstruction occur in multiple small areas of the
microvasculature and not in a uniform manner [4,55,56],
we cannot rule out the possibility of group A-like PfEMP1
involvement in localised EC activation in the brain micro-
Table 2 Age-adjusted logistic regression models
predicting respiratory distress (N = 130)
Respiratory distress
Models Explanatory variables OR (95% CI) P
1 $ Rosette frequency 5.7(1.6, 20.6) 0.008
2 $ Group A-like 1.76(0.49, 6.34) 0.39
3 ang-2 4.1(2.0, 8.55) 0.0001
4 $ parasite density (peripheral) 2.59(1.56, 4.3) 0.0002
5 PfHRP2 1.58(1.18, 2.11) 0.002
6 $ IE surface antibodies 0.98(0.96, 1.0) 0.1
7 Rosette frequency 3.0(0.7, 12.9) 0.14
ang-2 3.5(1.67, 7.3) 0.001‡
8 $ Rosette frequency 2.0(0.51, 8.3) 0.3
parasite density (peripheral) 2.4(1.4, 4.0) 0.001‡
9 Rosette frequency 3.54(0.93- 13.42) 0.06
PfHRP2 1.5(1.11, 2.03) 0.008
10 ang-2 3.2(1.5, 6.99) 0.003‡
parasite density (peripheral) 2.17(1.30, 3.62) 0.003‡
11 Ang-2 3.35(1.56, 7.20) 0.002‡
PfHRP2 1.37(1.0, 1.87) 0.044
12 Rosette frequency 1.25(0.26, 6.0) 0.78
Parasite density (peripheral) 2.1(1.24, 3.6) 0.006‡
ang-2 3.1(1.4, 6.9) 0.005‡
13 rosette 2.18(0.49, 9.70) 0.31
PfHRP2 1.34(0.98, 1.83) 0.07
Ang-2 3.01(1.38, 6.56) 0.005‡
The analysis in this table is similar to that in Table 1 except the outcome of
interest is respiratory distress. Ang-2 seems to be in the causal pathway linking
rosetting frequency to respiratory distress (models 7, 12 and 13). ‡ = variables
that improved the fit of the model using LR χ2 improvement test. The analysis
in this table is based on 130 samples with rosette frequency data. PfHRP2 data
was obtained for 126 out of the 130 samples. $ indicate models published in
[10] and repeated here for comparison.
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vasculature which is not reflected in the measured plasma
ang-2 levels. The latter possibility has been suggested by a
recently published study that found fibrin deposition oc-
curring more commonly in CM cases than fatal encephalo-
pathic controls that is restricted to microvessels with
sequestered IE [27].
Conclusion
Further studies are needed to determine whether sys-
temic endothelial activation observed in malaria is caus-
ally related to cytoadherence or invoked by circulating
factors such as microparticles and other IE derived
toxins. In Future studies it will be important to explore
the role of cytoadhesion to endothelial protein C recep-
tor and use var expression assays that more directly
measure the levels of domain cassettes known to bind to
this receptor.
Additional file
Additional file 1: Figure S2. Patients characteristics. Figure S2. The
relationship between ang‐2 and base‐excess.
Figure 4 Relationship between rosette, ang-2 and respiratory distress. A plot of odds ratio and 95% CI obtained from age-adjusted logistic
regression predicting respiratory distress using; A) rosetting frequency (unadjusted) and ang-2-adjusted, B) ang-2(unadjusted) and rosette
frequency-adjusted. Asterisk indicate significance. Scatter plots showing the relationship between C) rosetting frequency and peripheral parasit-
emia, D) rosetting frequency and PfHRP2, E) ang-2 and peripheral parasitemia, F) ang-2 and PfHRP2.
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